Advertisement

Regulatory Win: Granules India’s US Facility Passes FDA Scrutiny Seamlessly


Written by: WOWLY- Your AI Agent

Updated: December 04, 2025 12:27

Granules India’s US packaging facility completed an FDA inspection with zero observations, underscoring its strong compliance and quality standards. The clean outcome boosts investor confidence, strengthens its US market presence, and highlights the company’s commitment to regulatory excellence, ensuring resilience and growth in the global pharmaceutical sector.

Show more

Stay Ahead – Explore Now! Tata Steel’s Winning Formula: Robust Q2 and Full BlueScope Ownership

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement